Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stevenson

Showing results (231-240 of 288) with videos related to

Pageof 29
Sort By:
Plos One|October 26, 2018
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patientsMonica Khunger, Pradnya Dinkar Patil, Arjun Khunger, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2004
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignanciesJoshua H Bilenker, James P Stevenson, Keith T Flaherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I trial of combretastatin a-4 phosphate with carboplatinJoshua H Bilenker, Keith T Flaherty, Mark Rosen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreasJ P Stevenson, R M Scher, R Kosierowski, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancerM L Veronese, J P Stevenson, W Sun, et al.
Transplantation Proceedings|June 24, 1998
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantationN A Undre, J van Hooff, M Christiaans, et al.
Transplantation Proceedings|March 20, 1999
Low systemic exposure to tacrolimus correlates with acute rejectionN A Undre, J van Hooff, M Christiaans, et al.
Journal of Oncology Practice|January 14, 2016
Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An ASCO Quality Training Program Project of the Cleveland Clinic Taussig Cancer InstituteLindsey Martin Goodman, Machelle B Moeller, Abdel-Ghani Azzouqa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A)J P Stevenson, K S Yao, M Gallagher, et al.
Environmental Science & Technology|February 16, 2006
Spatially complex distribution of dissolved manganese in a fjord as revealed by high-resolution in situ sensing using the autonomous underwater vehicle AutosubP J Statham, D P Connelly, C R German, et al.
Pageof 29

Showing results (231-240 of 288) with videos related to

Sort By:
Pageof 29
Plos One|October 26, 2018
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patientsMonica Khunger, Pradnya Dinkar Patil, Arjun Khunger, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2004
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignanciesJoshua H Bilenker, James P Stevenson, Keith T Flaherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I trial of combretastatin a-4 phosphate with carboplatinJoshua H Bilenker, Keith T Flaherty, Mark Rosen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreasJ P Stevenson, R M Scher, R Kosierowski, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancerM L Veronese, J P Stevenson, W Sun, et al.
Transplantation Proceedings|June 24, 1998
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantationN A Undre, J van Hooff, M Christiaans, et al.
Transplantation Proceedings|March 20, 1999
Low systemic exposure to tacrolimus correlates with acute rejectionN A Undre, J van Hooff, M Christiaans, et al.
Journal of Oncology Practice|January 14, 2016
Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An ASCO Quality Training Program Project of the Cleveland Clinic Taussig Cancer InstituteLindsey Martin Goodman, Machelle B Moeller, Abdel-Ghani Azzouqa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A)J P Stevenson, K S Yao, M Gallagher, et al.
Environmental Science & Technology|February 16, 2006
Spatially complex distribution of dissolved manganese in a fjord as revealed by high-resolution in situ sensing using the autonomous underwater vehicle AutosubP J Statham, D P Connelly, C R German, et al.
Pageof 29